NicholasRBurwickMD
Hematology • Seattle, WAHematologic Oncology
Assistant Professor, University of Washington School of Medicine
Dr. Burwick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2011
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
Duke University School of MedicineClass of 2004
Certifications & Licensure
WA State Medical License 2008 - 2026
MA State Medical License 2006 - 2009- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 340 citationsCXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapyAbdel Kareem Azab, Judith Runnels, Costas Pitsillides, Anne-Sophie Moreau, Feda Azab
Blood. 2009-04-30 - 54 citationsImpaired ribosomal subunit association in Shwachman-Diamond syndromeNicholas Burwick, Scott A. Coats, Tomoka Nakamura, Akiko Shimamura
Blood. 2012-12-20 - 21 citationsThe eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma.Nicholas Burwick, Michael Y. Zhang, Pilar de la Puente, Abdel Kareem Azab, Teresa S. Hyun
Leukemia Research. 2017-04-01
Journal Articles
- Association of Monoclonal Gammopathy with Progression to ESKD Among US VeteransNicholas Burwick, MD, Journal of the American Society of Nephrology
- Glucocorticoids in Multiple Myeloma: Past, Present, and FutureNicholas Burwick, Sanjai Sharma, Annals of Hematology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
